Latest pancreatic cancer News | Page 2

AstraZeneca will highlight momentum of practice-changing cancer medicines across its robust pipeline at ASCO 2023
Oncosil Medical announces first patient treatment in Italy
Pancreatitis cases keep on ICUs
Deficiency causes appetite for meat
Amplia Therapeutics says third cohort enrolment completed in ACCENT clinical trial
Researcher shares his reason to run in HBF Run for a Reason
Researchers image live drug response and resistant ‘pockets’
First patient on trial in colorectal, gastric and ovarian cancer study
Pancreatic cancer carers sought for QIMR Berghofer study
Leading way in care for our firefighters
License agreement with KYM Biosciences for CMG901, a Claudin-18.2 antibody drug conjugate, completed
70 years of scientific excellence has brought significant benefits to Australia
Crucial medical research gets green light
Exposing tumours to bacteria converts immune cells to cancer killers
Exposing cancers to bacteria reminds first responder immune
Enhertu showed clinically meaningful and durable responses across multiple HER2-expressing tumour types in DESTINY-PanTumor02 Phase II trial
New conversations series to explore big questions and new frontiers
UNSW researchers receive more than $5.9m in Cancer Institute NSW grants
Eliminating partners of cancer
Australia Day honour for WEHI president
Ozempic helps people lose weight. But who should be able to use it?
Expansion of Prescribed Cancers List for Firefighters
Potential therapy for aggressive type of colon cancer shows promise
UNSW researchers receive more than $16m in Ideas Grants
$8 million awarded to UniSA researchers to tackle cancer, medicine harm, vascular disease and miscarriages
NHMRC awards Ideas Grants to Garvan researchers
Ask us anything. Pancreatic cancer
Pancreas models may save life
New chair for Destination NSW
Vaccination with senescent cells reduced tumor formation in mice
Funding Boost Supporting Cancer Research Leaders
Ludwig Chicago nanotechnology indicues therapeutic immune responses against multiple types of tumors
Resignation of Cr John Watson
Annual Report 2021-22
Researchers awarded five NHMRC Investigator Grants
Baylor College of Medicine recruiting volunteers for pancreatic cancer clinical trial
Noxopharm reports promising results from pancreatic cancer study
New research shows rates of obesity-related cancers quadrupled in generation
AstraZeneca aims to transform cancer outcomes with new data across industry-leading portfolio at ESMO 2022
Can new technology deliver pancreatic cancer breakthrough?
Hope for ‘inoperable’ cancer patients
Cool room temperature inhibited cancer growth in mice
New pancreatic cancer treatment available
Amplia Therapeutics’ trial to be presented at major US conference
CPTAC renews funding for proteogenomics research at Baylor
Lynparza recommended for approval in EU by CHMP as adjuvant treatment for patients with germline BRCA-mutated HER2-negative
Minimally invasive surgery helps cat with early pancreatic cancer
Know your risk for hereditary cancer